In conclusion, the studies presented here show that the use of bsAb targeting VISTA and PD-L1 antibodies results in a higher level of tumor cell lysis in pancreatic, breast and endometrial cancers than monospecific antibodies and their combination. The gene discussed is CD274; the disease is endometrial cancer.